The Pharmacy’s Cash Price for Her Generic Will Be $11. Her Part D Plan Will Charge $47. Paying Cash Will Save $36 but Won’t Count Toward Her $2,400 Out-of-Pocket Cap

Impact · against what's priced in

The rise in the Medicare Part D out-of-pocket cap to $2,400 in 2027 marginally increases financial liability for high-cost drug users, though this is largely a known regulatory trajectory. The behavior of patients opting for cash generics over plan copays represents a standard trade-off between immediate savings and progress toward the annual cap.

Scored by the NIS engine · methodology.

• generics
• healthcare costs
• insurance claims